Vasoactive intestinal peptide (VEP)-like immunoreactivity is present at low levels in the superior cervical ganglion of the adult rat, where immunostained neural processes, but only an occasional immunostained cell body, are found. However, when ganglia are maintained for 24 or 48 hr in organ culture, their content of VIP-like immunoreactivity increases 6-or 31-fold, respectively. When examined at 24 hr, the increase in VIP-like immunoreactivity is totally blocked by an inhibitor of RNA or protein synthesis. Many neuronal cell bodies and processes with immunoreactivity for VIP and the related peptide histidine isoleucine amide (PHI) are seen in cultured ganglia. In addition, VIP/PHI mRNA is abundant in cultured ganglia but only barely detectable in ganglia prior to culture. Under the same culture conditions, neuropeptide Y-like immunoreactivity increases to a small extent, and tyrosine hydroxylase activity and total ganglion protein remain unchanged. These results support the idea that adult sympathetic neurons exhibit plasticity in neuropeptide expression and that this plasticity, in the case of VIP, depends on changes in gene expression.Specific neurons can synthesize and release more than one neurotransmitter. For example, many adult sympathetic neurons synthesize and release both norepinephrine and neuropeptide Y (NPY), a small number synthesize and release acetylcholine and vasoactive intestinal peptide (VIP), and some use other combinations of amines and peptides (1). In addition, during-development, neurons can change the neurotransmitters they utilize. The best studied example is the ability of neonatal sympathetic neurons to start making acetylcholine and to reduce their synthesis of norepinephrine. Initially identified in cell culture, this phenomenon was subsequently shown to occur in vivo, during the development of the cholinergic sympathetic neurons that innervate the rat foot pad (2).In addition to changes in biogenic amine synthesis, the expression of colocalized neuropeptides in neonatal sympathetic neurons can also be regulated during development. Medium conditioned by cultured heart cells contains a factor that, in addition to producing a cholinergic "switch" in neonatal sympathetic neurons from the superior cervical ganglion (SCG), also increases their immunoreactivity for several peptides [i.e., VIP, substance P, somatostatin, but not NPY (3)]. Also, when sympathetic neurons innervating the foot pads in neonatal rats change from a noradrenergic to a cholinergic phenotype, they acquire immunoreactivity for VIP and calcitonin gene-related peptide (2). Finally, placing neonatal SCG in explant culture for 48 hr produces a large (50-fold) increase in the expression of substance P-like immunoreactivity (IR) (4).Much less attention has been paid to the possibility that alterations in transmitter phenotype occur in adult sympathetic neurons. With electrophysiological techniques, only a small percentage of adult sympathetic neurons were found to acquire cholinergic properties in cell culture (...